| Brian Eugene Elledge, DO | |
|
1000 E 100 N, Payson, UT 84651-1600 | |
| (801) 465-7041 | |
| (801) 465-7409 |
| Full Name | Brian Eugene Elledge |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1000 E 100 N, Payson, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174865455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 20A14904 (California) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 9848744-1204 (Utah) | Primary |
| Entity Name | Jun R. Chiong, Md, Mph, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093099046 PECOS PAC ID: 5597925974 Enrollment ID: O20120321000723 |
News Archive
A heart stent that slowly dissolves into the body is now available for patients with clogged arteries.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
In this Washington Post opinion piece, Bill Gates, co-founder of the Bill & Melinda Gates Foundation, cites declines in global child mortality rates as an example of how development aid works, and writes, "I am giving a report Thursday to the heads of the Group of 20 (G20) governments, including President Obama, suggesting creative ways for the world to continue investing in development despite fiscal constraints."
Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Eugene Elledge, DO Po Box 742353, Atlanta, GA 30374-2353 Ph: (310) 482-8403 | Brian Eugene Elledge, DO 1000 E 100 N, Payson, UT 84651-1600 Ph: (801) 465-7041 |
News Archive
A heart stent that slowly dissolves into the body is now available for patients with clogged arteries.
According to results from a Phase III safety and immunogenicity study presented today, Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine, [13-valent, adsorbed]) was shown to be immunogenic and generally well tolerated in healthy young children who had received at least three prior doses of Prevenar (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed). These data were presented today at the 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD) in Tel Aviv, Israel.
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.
In this Washington Post opinion piece, Bill Gates, co-founder of the Bill & Melinda Gates Foundation, cites declines in global child mortality rates as an example of how development aid works, and writes, "I am giving a report Thursday to the heads of the Group of 20 (G20) governments, including President Obama, suggesting creative ways for the world to continue investing in development despite fiscal constraints."
Taiga Biotechnologies, Inc. today announced that the company has received three new Small Business Innovation Research (SBIR) grants from the National Institutes of Health, totaling $1.7 million. This adds to the two previous grants awarded to Taiga for various applications of its proprietary technology platforms, for a total in NIH funding to date of over $2.1 million.
› Verified 9 days ago
Dr. Kevin Lee, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E 100 N, Payson, UT 84651 Phone: 801-465-7041 | |
Dr. Lyle Milton Kinikini, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 97 Professional Way, Payson, UT 84651 Phone: 801-429-8000 | |
Scott David Daniels, MD, MHA Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E 100 N, Payson, UT 84651 Phone: 801-465-7041 |